Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
| Metric | Canva | OpenEvidence |
|---|---|---|
| Total funding | $770M | $277M |
| Latest round | Series F | Series C |
| Amount | $200M | $800M |
| Date | Sep 2021 | Sep 2026 |
| Valuation | $40B | Undisclosed |
| Lead investors | T. Rowe Price | Undisclosed |
Scores, valuations, and signals for Canva, OpenEvidence, and 370+ companies. 5-min read every Tuesday.
Canva is the world's leading design platform with 250M+ users — valued at $48B with $770M raised. Track IPO timeline, funding rounds, and readiness score.
| Industry | Design & Creative |
| Stage | Pre-IPO |
| IPO Status | Private |
| Valuation | $42B |
| Total Funding | $770M |
| Headquarters | Sydney, Australia |
OpenEvidence is an AI-powered clinical assistant that helps physicians instantly access synthesized medical evidence to make better patient care decisions at the point of care.
| Industry | Healthcare Technology |
| Stage | Series C |
| IPO Status | Private |
| Valuation | $3.0B |
| Total Funding | $277M |
| Headquarters | Boston, MA |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Canva is valued at $42B. OpenEvidence is valued at $3.0B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Canva reported 4000000000 revenue in 2025. OpenEvidence's revenue is not publicly disclosed. Revenue figures are sourced from TechStackIPO's company database and updated as new data becomes available.
Canva filed an S-1 in August 2026 and is actively in the IPO pipeline. OpenEvidence filed an S-1 in September 2026 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Canva has raised $770M. OpenEvidence has raised $277M.
Canva operates in Design & Creative, while OpenEvidence operates in Healthcare Technology.
Canva is a Design & Creative company valued at $42B with $770M raised. OpenEvidence is a Healthcare Technology company valued at $3.0B with $277M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Canva and OpenEvidence through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.